Baxter International, Inc. (BAX)
20.03
+0.79
(+4.11%)
USD |
NYSE |
Jun 09, 16:00
20.03
0.00 (0.00%)
After-Hours: 20:00
Baxter International SG&A Expense (Quarterly) : 728.00M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| DexCom, Inc. | 349.70M |
| Becton, Dickinson & Co. | 1.213B |
| ICU Medical, Inc. | 154.57M |
| Abbott Laboratories | 3.74B |
| Boston Scientific Corp. | 1.781B |